TRDA ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/5/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-1.01
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)898.00K
Entrada Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Entrada Therapeutics Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Entrada Therapeutics Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Entrada Therapeutics Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Entrada Therapeutics Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
TRDA ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
TRDA FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-3.47-297.52%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)25.42M-87.94%
Entrada Therapeutics Inc(TRDA) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -1.01/-1.05 | 898.00K/411.43K | 3.54% | 118.26% |
| 5/7/2026 | 03/2026 | -0.95/-1.04 | 875.00K/1.39M | 8.43% | -37.20% |
| 2/26/2026 | 12/2025 | -0.94/-1.15 | 1.30M/10.91M | 18.15% | -88.10% |
| 11/6/2025 | 09/2025 | -1.06/-0.94 | 1.61M/13.70M | -13.24% | -88.22% |
| 8/6/2025 | 06/2025 | -1.04/-0.85 | 1.95M/9.65M | -23.03% | -79.80% |
| 5/8/2025 | 03/2025 | -0.42/-0.79 | 20.56M/10.17M | 46.47% | 102.12% |
| 2/27/2025 | 12/2024 | 0.03/-0.67 | 37.40M/13.12M | 104.13% | 185.04% |
| 11/5/2024 | 09/2024 | -0.35/-0.73 | 19.57M/12.32M | 52.56% | 58.83% |